AstraZeneca ended a Phase 2 trial of an experimental opioid use disorder treatment, the UK pharma confirmed to Endpoints News.
The termination was due to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
EQS Newswire / 06/09/2024 / 10:21 UTC+8 Jinxin Fertility Group Limited has always been highly regarded by market investors as a stock featured scarcity on
A multidisciplinary team of clinicians, engineers, and neuroscientists has identified a unique biomarker in the brain that indicates recovery from treatment-resistant depression, utilizing deep brain
What You Should Know: – Withings, the pioneer of hybrid smartwatches, unveils its latest innovation: ScanWatch Nova. – This timepiece seamlessly blends cutting-edge health-tracking technology